WASHINGTON — President Trump typically brags that the “most-favored nation” offers he struck with drugmakers have set the nation on a brand new path to not paying greater than its fair proportion for prescription drug prices. However many particulars of the agreements haven’t been launched by the administration and the businesses, together with their period.
Now STAT has discovered from Securities and Alternate Fee filings that, not less than for among the firms, these offers final three years.
The agreements range by every of the 16 firms which have struck them, however there are a number of commonalities.
This text is unique to STAT+ subscribers
Unlock this text — plus each day protection and evaluation of the pharma business — by subscribing to STAT+.
Have already got an account? Log in
View All Plans